CPT code 87592: Gonorrhea test, quantitative nucleic acid2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Quantitative nucleic-acid testing for Neisseria gonorrhoeae, reported when the laboratory measures the target rather than performing direct- or amplified-probe detection.
Medicare pays $42.84 for 87592 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$42.84
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 87592 covers
An assay for Neisseria gonorrhoeae nucleic acid produces a quantitative result. A clinical laboratory reports 87592 when the test performed quantifies the target; direct-probe detection and amplified-probe detection are distinct services represented by 87590 and 87591. This code is specific to gonorrhoeae, distinguishing it from nucleic-acid tests for other organisms.
Report 87592 when the laboratory performs quantitative testing, rather than choosing 87590 or 87591 solely because the target is the same organism. Medicare pays this test only through the CLFS. The 2026 national amount is $42.84, unchanged from 2020 through 2026; one amount applies across states and localities, with no office-versus-facility difference. The physician fee schedule excludes the test by statute.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 87592
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 87592. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 87592 with status X (excluded by statute), so the test itself is paid only from the CLFS.
87592 on the lab fee schedule since 2020
87592 · CLFS 2026 Q4 (current)
$42.84
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
87592 compared with similar tests
- 87590Gonorrhea testDirect nucleic acid probe$26.88
- Choose 87590 for direct-probe detection of Neisseria gonorrhoeae; 87592 is for quantitative testing.
- 87591Gonorrhea testAmplified DNA probe$35.09
- Choose 87591 for amplified-probe detection of Neisseria gonorrhoeae; 87592 identifies quantitative testing.
- 87491Chlamydia testAmplified nucleic acid detection$35.09
- 87491 tests for Chlamydia trachomatis using amplified-probe detection. Code 87592 tests for Neisseria gonorrhoeae and reports quantification.
87592 billing questions
When should this code be chosen over 87591?
Use 87592 when the laboratory quantifies Neisseria gonorrhoeae nucleic acid. Use 87591 for amplified-probe detection rather than quantification.
How does 87592 differ from 87590?
87592 reports quantitative testing. Code 87590 is for direct-probe detection of Neisseria gonorrhoeae.
Can this code be reported with a chlamydia test?
Gonorrhoeae and Chlamydia trachomatis testing may be performed during the same encounter. Report each code only for the test actually performed.
Does Medicare pay this test under the physician fee schedule?
No. Medicare pays 87592 through the CLFS, using one national amount across localities and care settings.
What should documentation support?
Documentation should support quantitative gonorrhoeae nucleic-acid testing as the service performed. Direct-probe and amplified-probe detection are distinct services.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 87592 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist